Back to search

Article

BTK Inhibitors and BTK Degraders for the Treatment of Mantle Cell Lymphoma - Current Status and Perspectives

2026-07-13

Abstract excerpt

The introduction of Bruton tyrosine kinase inhibitors (BTKis) has significantly improved prognosis in the treatment of MCL. BTK inhibitors have demonstrated strong activity in the treatment of relapsed/refractory patients with mantle cell lymphoma (MCL), and several trials indicate that they also have potential as first-line treatment. Furthermore, combining BTKis with immunochemotherapy has enabled time-limited t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d778685-e1ce-55ec-8399-8e0ac8852146
DOI
10.20944/preprints202607.0843.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BTK Inhibitors and BTK Degraders for the Treatment of Mantle Cell Lymphoma - Current Status and PerspectivesDOI 10.20944/preprints202607.0843.v1
Novel treatment for mantle cell lymphoma - impact of BTK inhibitors and beyond.Semantic proximity
Rocbrutinib in Covalent BTK Inhibitor Exposed Relapsed or Refractory Mantle Cell Lymphoma: a Phase 2, Open-label, Multicenter, Single-arm StudySemantic proximity
SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia.Semantic proximity
Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphomaSemantic proximity
The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future DirectionsSemantic proximity
BTK inhibitors in CLL: second-generation drugs and beyond.Semantic proximity
The B cell receptor signaling pathway in mantle cell lymphomaSemantic proximity
New Means and Challenges in the Targeting of BTK.Semantic proximity
Next-generation Bruton's Tyrosine Kinase (BTK) Inhibitors Potentially Targeting BTK C481S Mutation- Recent Developments and Perspectives.Semantic proximity
Mantle cell lymphoma: evolving management strategies.Semantic proximity
Unraveling MCL biology to understand resistance and identify vulnerabilitiesSemantic proximity
Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and BeyondSemantic proximity
Select a neighboring publication to make it the new centre.